Davis's Drug Guide
donislecel
General
Pronunciation:
doe-nis-le-sel
Trade Name(s)
- Lantidra
Ther. Class.
none assigned
Pharm. Class.
temporary class
allogeneic cellular therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Donislecel." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580178/all/donislecel.
Vallerand AHA, Sanoski CAC. Donislecel. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580178/all/donislecel. Accessed August 6, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Donislecel. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580178/all/donislecel
Vallerand AHA, Sanoski CAC. Donislecel [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 06]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580178/all/donislecel.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - donislecel
ID - 3580178
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580178/all/donislecel
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -
